Metagenomi Technologies, LLC (MGX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

MGX Metagenomi Technologies, LLC

Watchlist

2.700
+0.010+0.37%

Close Sep 13 16:00 ET

2.830
+0.130+4.81%

Post 20:02 ET

101.06MMarket Cap-1348P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

H.C. Wainwright Maintains Metagenomi Technologies, LLC(MGX.US) With Buy Rating, Maintains Target Price $7
Moomoo NewsSep 6 06:31 ET · Ratings
Metagenomi Price Target Maintained With a $15.00/Share by Chardan Capital
Dow JonesSep 5 15:34 ET · Ratings
BMO Capital Maintains Metagenomi Technologies, LLC(MGX.US) With Buy Rating, Maintains Target Price $17
Moomoo NewsSep 4 07:31 ET · Ratings
Express News | Metagenomi Announces Durable Twelve-Month Preclinical Data for Hemophilia A Program, Reports Consistent Factor VIII Activity and Good Tolerance; Program On Track For IND Filing In 2026
BenzingaSep 3 16:15 ET
Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference
newsfilter.ioAug 29 19:32 ET
Metagenomi to Participate in Upcoming Investor Conferences
newsfilter.ioAug 28 18:10 ET

Comments

Jaguar8

Sep 3 15:05

NEWS

$Metagenomi Technologies, LLC (MGX.US)$
Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months
Metagenomi (Nasdaq: MGX) has announced promising 12-month durability data for its lead hemophilia A program, MGX-001.
The preclinical study in nonhuman primates (NHPs) demonstrated durable Factor VIII (FVIII) activity levels through twelve months, with two NHPs showing normal/near-normal levels (82% and 41%...

Jaguar8

Aug 30 02:56

NEWS THUR AH

$Metagenomi Technologies, LLC (MGX.US)$
Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference
Metagenomi (Nasdaq: MGX) presented advancements in its AI-enabled SMART Editing Platform at the CRISPR Frontiers Conference. The company showcased AI-generated compact SMART nucleaseswith robust genome editing activity in mammalian cells. These tools, fitting within size-constrained delivery technologies, may ena...